Brief: Totality Of Evidence From Beat-Hf Study Shows Cvrx’S Barostim Provides Long-Term Benefits For Patients With Heart Failure

Cvrx

21/03/2023 15:14

March 21 (Reuters) - CVRx Inc  CVRX.O :
    * TOTALITY OF EVIDENCE FROM BEAT-HF STUDY SHOWS CVRX’S
BAROSTIM
PROVIDES LONG-TERM BENEFITS FOR PATIENTS WITH HEART FAILURE
    * CVRX INC - ANTICIPATES THAT REGULATORY SUBMISSION TO THE
FDA FOR
EXPANDED LABELING WILL BE MADE IN THE COMING MONTHS FOR BAROSTIM
    * CVRX INC - WE LOOK FORWARD TO SUBMITTING BEAT-HF STUDY NEW
DATA
TO FDA TO PURSUE EXPANDED LABELING FOR BAROSTIM

Source text for Eikon:  ID: 

 ((Reuters.Briefs@thomsonreuters.com;))